OptimizeRx Corp.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $145.2M
- Price
- $7.71
- % Change (Daily % change from the live per-ticker quote feed.)
- -3.14%
- Volume
- 130.9K
About
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
Quick stats
Shares outstanding18.8M
Computed float16.4M
Float / shares86.9%
Key info
SectorHealthcare
IndustryMedical - Healthcare Information Services
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001448431
Websitehttps://www.optimizerx.com
AI Summary
AI-generated1/21
standardbullishexecutive change
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
OptimizeRx announced a planned finance leadership transition, appointing Andy D’Silva as Chief Financial Officer and Heather Favazza as Chief Accounting Officer effective January 1, 2027.
Current CFO Ed Stelmakh will serve through the end of 2026 and remain as a Strategic Advisor through 2027 to ensure a seamless transfer of responsibilities.
D’Silva is promoted from Chief Business Officer, while Favazza moves up from Corporate Controller, reflecting the company's deep internal succession planning.